Geistlich unveils vallos™ - a new demineralized allograft that sets the pace for regeneration
/PRNewswire/ -- Geistlich Pharma North America Inc. is setting the pace for expanded treatment options with the introduction of vallos™, our first...
Source: prnewswire.com